In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Ozempic Is About to Go Generic in India, China and Canada
Originally reported by New York Times
Related Articles
Iran War Live Updates: Fragile Cease-Fire Takes Hold as Both Sides Claim Victory
Global relief at the pause in fighting was tempered by uncertainty over what happens next. Israel declared its support f...
Even as They Praise Iran Cease-Fire, World Leaders Are Whipsawed by Trump
Across Europe and the globe, the war has damaged economies, roiled politics and underscored a lack of options in dealing...
China Pressed Iran Toward Cease-fire, Iranian Officials Say
Beijing appeared to have helped push Tehran to accept the two-week deal with the United States, reflecting China’s growi...
Ceasefire wins Trump instant gratification but Iran can enter talks with stronger hand
US is in weaker position than before war as Tehran has shown capacity to inflict pain on Trump administrationMiddle East...